Navellier & Associates’s Boston Scientific BSX Stock Holding History

Navellier & Associates’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-42,779	Closed	-$4.18M	–	338
2025 Q3	$4.18M	Sell	42,779 -4,814	-10%	-$499K	0.42%	65
2025 Q2	$5.11M	Sell	47,593 -20,519	-30%	-$2.08M	0.63%	44
2025 Q1	$7.1M	Buy	68,112 +63,142	+1,270%	+$6.36M	0.98%	23
2024 Q4	$444K	Hold	4,970	–	–	0.05%	245
2024 Q3	$416K	Hold	4,970	–	–	0.06%	244
2024 Q2	$383K	Hold	4,970	–	–	0.04%	271
2024 Q1	$340K	Buy	4,970 +250	+5%	+$16.1K	0.04%	278
2023 Q4	$273K	Buy	+4,720	New	+$252K	0.04%	285
2014 Q3	–	Sell	-31,244	Closed	-$399K	–	328
2014 Q2	$399K	Sell	31,244 -4,929	-14%	-$64.1K	0.02%	216
2014 Q1	$489K	Sell	36,173 -352	-1%	-$4.62K	0.02%	180
2013 Q4	$439K	Buy	+36,525	New	+$432K	0.02%	197

Other funds holding BSX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Navellier & Associates's BSX Position: Q4 2025 in Review

Navellier & Associates sold out of Boston Scientific (BSX) in Q4 2025, closing a stake of 42,779 shares — an estimated $4.18M sold.

Navellier & Associates first reported a position in BSX in Q4 2013 and held it in 11 quarters. The position peaked at $7.1M in Q1 2025. 1,784 funds tracked by Wall St. Rank hold BSX as of Q4 2025.

Navellier & Associates reported no remaining Boston Scientific position as of Q4 2025 after selling out during the quarter.
Navellier & Associates sold 42,779 Boston Scientific shares in Q4 2025, an estimated $4.18M.
Navellier & Associates first reported a position in Boston Scientific in Q4 2013 and held it in 11 quarters.
Navellier & Associates's Boston Scientific position peaked at $7.1M in Q1 2025.
1,784 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2025.

Based on Navellier & Associates's 13F filing for Q4 2025, filed 3 Feb 2026.